{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:18:14Z","timestamp":1792149494613,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jad.2009.10.033","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T14:55:40Z","timestamp":1258642540000},"page":"1-9","source":"Crossref","is-referenced-by-count":96,"title":["Valproate for the treatment of acute bipolar depression: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"122","author":[{"given":"L.A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.R.","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Azorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2009.10.033_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1440-1614.2004.01356.x","article-title":"Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder","volume":"38","author":"Australian and New Zealand College of Psychiatrists","year":"2004","journal-title":"Aust. NZ J. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-0327(96)01421-8","article-title":"Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice","volume":"43","author":"Benazzi","year":"1997","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.10.033_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events","volume":"26","author":"Bradburn","year":"2007","journal-title":"Stat. Med."},{"key":"10.1016\/j.jad.2009.10.033_bib4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4088\/JCP.v65n1109","article-title":"Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample","volume":"65","author":"Calabrese","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib6","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4088\/JCP.v69n1014","article-title":"International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression","volume":"69","author":"Calabrese","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalproex in the treatment of bipolar depression: a placebo-controlled study","volume":"85","author":"Davis","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.10.033_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0165-0327(00)00279-2","article-title":"Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use","volume":"65","author":"Ghaemi","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.10.033_bib10","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4088\/JCP.v68n1203","article-title":"Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study","volume":"68","author":"Ghaemi","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib11","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J. Psychopharmacol. (Oxf., England)"},{"key":"10.1016\/j.jad.2009.10.033_bib13","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2008"},{"key":"10.1016\/j.jad.2009.10.033_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.jad.2009.10.033_bib15","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"Hirschfeld","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4088\/JCP.v64n0111","article-title":"Screening for bipolar disorder in the community","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3122\/jabfm.18.4.233","article-title":"Screening for bipolar disorder in patients treated for depression in a family medicine clinic","volume":"18","author":"Hirschfeld","year":"2005","journal-title":"J. Am. Board of Family Practice\/Am. Board Family Practice"},{"key":"10.1016\/j.jad.2009.10.033_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib19","series-title":"Assessing the Quality of Randomised Controlled Trials","author":"Juni","year":"2001"},{"key":"10.1016\/j.jad.2009.10.033_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2009.10.033_bib22","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.10.033_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib24","series-title":"Presented at the 48th NCDEU Meeting: New Approaches for Mental Health Interventions, Phoenix, Arizona, USA May 27\u201330 2008","article-title":"A Double-blind, Placebo-controlled Study of Divalproex Extended-release in Newly Diagnosed Mood Stabiliser Naive Patients with Acute Bipolar I or II Depression","author":"Muzina","year":"2008"},{"key":"10.1016\/j.jad.2009.10.033_bib25","series-title":"The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. National Clinical Practice Guideline Number 38","author":"National Institute for Health and Clinical Excellence","year":"2006"},{"key":"10.1016\/j.jad.2009.10.033_bib26","series-title":"Presented at the 40th Annual Meeting of the American College of Neuropsychopharmacology December 9\u201313, 2001 San Juan, Puerto Rico","article-title":"Divalproex versus Placebo for the Treatment of Biolar Depression","author":"Sachs","year":"2001"},{"key":"10.1016\/j.jad.2009.10.033_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.10.033_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies","volume":"28","author":"Thase","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.10.033_bib29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.10.033_bib30","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-009-5062-1","article-title":"Pregnancy and epilepsy: what should we tell our patients?","volume":"256","author":"Tomson","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jad.2009.10.033_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-0327(01)00434-7","article-title":"Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression","volume":"67","author":"Winsberg","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.10.033_bib32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2009.10.033_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.266.1.93","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials","volume":"266","author":"Yusuf","year":"1991","journal-title":"Jama"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709004959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709004959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T23:30:10Z","timestamp":1544830210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032709004959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0165032709004959"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2009.10.033","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}